HOME >> BIOLOGY >> NEWS
From Alzheimer's to schizophrenia: SNM reveals latest MI/NM research at annual meeting

RESTON, Va.--Researchers--covering the most recent advances in understanding, diagnosing and treating heart and brain diseases and cancer--release their findings in more than 1,600 scientific abstracts during SNM's 53rd Annual Meeting June 37 at the San Diego Convention Center.

More than 4,000 physicians, technologists, scientists and pharmacists will attend this meeting, the world's largest event for molecular imaging and nuclear medicine professionals. The educational and scientific program at the 53rd Annual Meeting is tailored to provide attendees with the most current and important information available in the field. SNM and SNMTS present about 100 continuing education courses focusing on PET/CT, cardiovascular nuclear medicine, brain imaging, pediatrics, oncology and therapy, thyroid cancer and radiation safety.

"Medical practitioners, technologists, scientists, physicists and pharmacists from around the world come to this premier scientific and educational event to discover just how far molecular imaging and nuclear medicine have pushed our understanding of human disease," said SNM President Peter S. Conti, professor of radiology, clinical pharmacy and biomedical engineering at the University of Southern California, Los Angeles, and director of the PET Imaging Science Center at USC's Keck School of Medicine. "From Alzheimer's to schizophrenia, from breast cancer to thyroid cancer, molecular imaging and nuclear medicine research have a proven record of leading to improvements in the diagnosis and treatment of life-threatening diseases that affect millions each year," added Conti, speaking on behalf of the society, which has more than 16,000 physician, technologist and scientist members in 78 countries.

"These are exciting times for all molecular imaging/nuclear medicine professionals, and SNM's Annual Meeting is the place to find the research, education, products and services essential to delivering the highest-quality patient care,"
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-708-9000
Society of Nuclear Medicine
12-Apr-2006


Page: 1 2 3

Related biology news :

1. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
2. Link identified between Alzheimers disease and glaucoma
3. UCF research links proteins, stem cells and potential Alzheimers treatment
4. Journal of Alzheimers Disease achieves significant impact factor
5. Alzheimers prevention role discovered for prions
6. Cloned pigs help scientists towards a breakthrough in Alzheimers
7. Alzheimers drug based on Purdue -- designed inhibitor begins clinical trials
8. Paving the way toward a vaccine against Alzheimers disease
9. Genetic fellow traveler discovered in Alzheimers
10. New clues to stroke role in Alzheimers
11. Research team identifies new Alzheimers gene

Post Your Comments:
(Date:5/18/2013)... FL (May 18, 2013) Research presented at ... managing digestive health through diet and lifestyle. ... plagued by reduced muscle strength, fatigue and poor ... when patients are in remission. A randomized, double ... that vitamin D supplementation corresponded to significant relief ...
(Date:5/17/2013)... provide the white noise of the South, but the night ... Southern air hangs heavy from the humidity and the sounds ... 140 species of frogs, toads and salamanders, is the center ... and swamps are the auditorium for their symphonic choruses, the ... Initiative, or ARMI, have front-row seats. , Amphibians, ...
(Date:5/17/2013)... proteins in the brain responsible for protecting nerve cells ... increase cell survival. , The discovery, made by researchers ... the EMBO journal with additional comment in ... stroke and other brain diseases. , The research builds ... protein, known as SUMO, responsible for controlling the chemical ...
Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4SUMO wrestling cells reveal new protective mechanism target for stroke 2
(Date:5/17/2013)... transplant rejection occurs when the transplant recipient,s immune system ... it. It was previously thought that T cells, the ... by molecules known as chemokines in order to migrate ... Journal of Clinical Investigation , Fadi Lakkis and ... demonstrate that chemokine stimulation of T cells is not ...
(Date:5/17/2013)... The new Public-Private Partnership (PPP) in ... association’s recent annual meeting drew praise from community leaders ... who called the action “a huge step forward … ... European innovation.” , The Board of Stakeholders voted to ... PPP at its 29 April meeting in Brussels, which ...
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)...  Insero Health, Inc., a company developing natural compounds ... neurological disorders, is today reporting top-line results from a ... patients with drug-resistant epilepsy.  The data are being presented ... meeting by Dr. Steven Schachter , ... Advisory Board.  In this study, INS001 appeared safe and ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
Cached News: